Christine T Mui
Examiner (ID: 15280, Phone: (571)270-3243 , Office: P/1797 )
Most Active Art Unit | 1797 |
Art Unit(s) | 1777, 1709, 1797, 1774 |
Total Applications | 1416 |
Issued Applications | 1043 |
Pending Applications | 77 |
Abandoned Applications | 296 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 840297
[patent_doc_number] => 07390625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-24
[patent_title] => 'Apoptosis-associated protein and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/535931
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 37424
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/390/07390625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535931 | Apoptosis-associated protein and use thereof | Nov 19, 2003 | Issued |
Array
(
[id] => 5857838
[patent_doc_number] => 20060228326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Active specific immunotherapy of cancer metastasis'
[patent_app_type] => utility
[patent_app_number] => 10/532551
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21215
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532551
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532551 | Active specific immunotherapy of cancer metastasis | Oct 20, 2003 | Abandoned |
Array
(
[id] => 8114347
[patent_doc_number] => 08158385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Cell death-inducing agent'
[patent_app_type] => utility
[patent_app_number] => 10/530696
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 51
[patent_no_of_words] => 15532
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158385.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530696 | Cell death-inducing agent | Oct 9, 2003 | Issued |
Array
(
[id] => 7286925
[patent_doc_number] => 20040146938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods of generating and screening for proteases with altered specificity'
[patent_app_type] => new
[patent_app_number] => 10/677977
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20895
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146938.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677977
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677977 | Methods of generating and screening for proteases with altered specificity | Oct 1, 2003 | Abandoned |
Array
(
[id] => 5100708
[patent_doc_number] => 20070183970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Chimeric, human and humanized anti-granulocyte antibodies and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/672278
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38809
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20070183970.pdf
[firstpage_image] =>[orig_patent_app_number] => 10672278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/672278 | Chimeric, human and humanized anti-granulocyte antibodies and methods of use | Sep 28, 2003 | Issued |
Array
(
[id] => 7675327
[patent_doc_number] => 20040126791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Compositions and methods for treating trail-resistant cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/666458
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11695
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10666458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/666458 | Compositions and methods for treating trail-resistant cancer cells | Sep 18, 2003 | Abandoned |
Array
(
[id] => 5828906
[patent_doc_number] => 20060063710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Flj20647s as modifiers of the p21 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/528168
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14753
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528168 | Flj20647s as modifiers of the p21 pathway and methods of use | Sep 14, 2003 | Abandoned |
Array
(
[id] => 7352050
[patent_doc_number] => 20040048318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Method for screening anti-proliferative compounds and method for inhibiting tumor growth'
[patent_app_type] => new
[patent_app_number] => 10/416669
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3698
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416669 | Method for screening anti-proliferative compounds and method for inhibiting tumor growth | Sep 2, 2003 | Abandoned |
Array
(
[id] => 5595700
[patent_doc_number] => 20060159616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Methods for detecting endocrine cancer'
[patent_app_type] => utility
[patent_app_number] => 10/526111
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 28484
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526111 | Methods for detecting endocrine cancer | Aug 27, 2003 | Abandoned |
Array
(
[id] => 5672945
[patent_doc_number] => 20060178300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Heterocarpine, a plant-derived protein with anti-cancer properties'
[patent_app_type] => utility
[patent_app_number] => 10/522457
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5272
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522457 | Heterocarpine, a plant-derived protein with anti-cancer properties | Aug 24, 2003 | Issued |
Array
(
[id] => 5672945
[patent_doc_number] => 20060178300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Heterocarpine, a plant-derived protein with anti-cancer properties'
[patent_app_type] => utility
[patent_app_number] => 10/522457
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5272
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522457 | Heterocarpine, a plant-derived protein with anti-cancer properties | Aug 24, 2003 | Issued |
Array
(
[id] => 5642626
[patent_doc_number] => 20060281081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Method of diagnosing colon and gastric cancers'
[patent_app_type] => utility
[patent_app_number] => 10/526326
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 33463
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10526326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526326 | Method of diagnosing colon and gastric cancers | Aug 18, 2003 | Abandoned |
Array
(
[id] => 7254914
[patent_doc_number] => 20050075302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Immune stimulation by phosphorothioate oligonucleotide analogs'
[patent_app_type] => utility
[patent_app_number] => 10/643141
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7692
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643141 | Immune stimulation by phosphorothioate oligonucleotide analogs | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7421783
[patent_doc_number] => 20040229229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Use of multiple recombination sites with unique specificity in recombinational cloning'
[patent_app_type] => new
[patent_app_number] => 10/640422
[patent_app_country] => US
[patent_app_date] => 2003-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 107523
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640422 | Use of multiple recombination sites with unique specificity in recombinational cloning | Aug 13, 2003 | Issued |
Array
(
[id] => 916828
[patent_doc_number] => 07323304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor'
[patent_app_type] => utility
[patent_app_number] => 10/524544
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8595
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524544 | Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor | Aug 6, 2003 | Issued |
Array
(
[id] => 7127268
[patent_doc_number] => 20050059012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Diagnosis of ZD1839 resistant tumors'
[patent_app_type] => utility
[patent_app_number] => 10/633486
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 36630
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10633486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/633486 | Diagnosis of ZD1839 resistant tumors | Jul 30, 2003 | Abandoned |
Array
(
[id] => 6911867
[patent_doc_number] => 20050175625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Mesothelin vaccines and model systems'
[patent_app_type] => utility
[patent_app_number] => 10/618088
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22920
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618088 | Mesothelin vaccines and model systems | Jul 13, 2003 | Abandoned |
Array
(
[id] => 101438
[patent_doc_number] => 07727526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Use of PTHrP antagonists for treating renal cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 10/520085
[patent_app_country] => US
[patent_app_date] => 2003-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 12574
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520085
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520085 | Use of PTHrP antagonists for treating renal cell carcinoma | Jul 3, 2003 | Issued |
Array
(
[id] => 5895652
[patent_doc_number] => 20060004191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Modified sodium iodide symporter proteins and genes for imaging and cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/519183
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12344
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20060004191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519183 | Modified sodium iodide symporter proteins and genes for imaging and cancer therapy | Jun 24, 2003 | Abandoned |
Array
(
[id] => 5661069
[patent_doc_number] => 20060251665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/515871
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 12301
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515871 | Vaccines | May 22, 2003 | Abandoned |